Want to create an interactive transcript for this episode?
Podcast: High Truths on Drugs and Addiction
Episode: Episode #127 High Truths on Drugs and Addiction with Dr. Brooks Gentry and Monoclonal Antibody Treatment For Methamphetamine Use Disorder
Description: What are some upcoming innovations for methamphetamine use disorder? Learn from Dr. Brooks Gentry how monoclonal antibodies can be the new MAT for meth.
Intervexion Therapeutics
Outlast Study
W. Brooks Gentry, MD
Dr. Brooks Gentry is a Professor in the Department of Anesthesiology at the University of Arkansas for Medical Sciences (UAMS), where he has served as Vice-Chair for Research since 2002, and a Professor in the Department of Pharmacology and Toxicology. He is also Chief Medical Officer for InterveXion Therapeutics and Chief Medical Officer for Kuria Therapeutics. Among many leadership roles and service posts on campus, he was...